VIRIVirios Therapeutics, Inc.

Nasdaq virios.com


$ 0.37 $ -0.02 (-4.75 %)    

Friday, 10-May-2024 10:51:38 EDT
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 0.3549
$ 0.36
$ 0.00 x 0
$ 0.39 x 100
$ 0.36 - $ 0.37
$ 0.28 - $ 2.42
213,396
na
6.83M
$ 1.90
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-10-2024 03-31-2024 10-Q
2 03-01-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-11-2023 06-30-2023 10-Q
5 05-12-2023 03-31-2023 10-Q
6 03-14-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-12-2022 06-30-2022 10-Q
9 05-13-2022 03-31-2022 10-Q
10 03-18-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-13-2021 06-30-2021 10-Q
13 05-14-2021 03-31-2021 10-Q
14 03-23-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 virios-therapeutics-q1-2024-gaap-eps-007-misses-004-estimate

Virios Therapeutics (NASDAQ:VIRI) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of...

 virios-therapeutics-announces-publication-of-international-patent-for-imc-2-covering-antiviral-treatment-of-long-covid

- New patent would extend coverage and expand potential value of Virios' antiviral pipeline globally –- Active Long-COVID c...

 virios-therapeutics-q4-2023-gaap-eps-006-beats-009-estimate

Virios Therapeutics (NASDAQ:VIRI) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $...

 virios-therapeutics-issues-shareholder-letter-highlighting-corporate-progress-and-key-upcoming-milestones-all-of-virios-employees-have-agreed-to-a-10-salary-compensation-reduction-in-exchange-for-future-vesting-stock-options

Virios Therapeutics, Inc. (NASDAQ:VIRI) (the "Company"), a development-stage biotechnology company focused on advancing...

 dow-gains-over-100-points-archer-daniels-midland-shares-plunge

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Monday. The Dow ...

 why-commscope-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of CommScope Holding Company, Inc. (NASDAQ: COMM) fell sharply during Monday’s session. B of A Securities analyst Tal L...

 crude-oil-surges-over-2-us-leading-economic-index-falls-in-december

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 150 points on Monday. The Dow traded...

 us-stocks-higher-nasdaq-jumps-100-points

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 100 points on Monday. Following the market op...

 why-jetblue-airways-shares-are-trading-lower-by-over-10-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of JetBlue Airways Corporation (NASDAQ: JBLU) fell sharply during Tuesday’s session.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION